 Heart Failure
"Heart Failure" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Descriptor ID |
D006333
|
| MeSH Number(s) |
C14.280.434
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heart Failure".
Below are MeSH descriptors whose meaning is more specific than "Heart Failure".
This graph shows the total number of publications written about "Heart Failure" by people in this website by year, and whether "Heart Failure" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1988 | 1 | 0 | 1 | | 1990 | 0 | 1 | 1 | | 1992 | 1 | 0 | 1 | | 1995 | 0 | 1 | 1 | | 1997 | 3 | 1 | 4 | | 1998 | 1 | 1 | 2 | | 2000 | 4 | 2 | 6 | | 2001 | 3 | 1 | 4 | | 2002 | 7 | 2 | 9 | | 2003 | 8 | 1 | 9 | | 2004 | 17 | 4 | 21 | | 2005 | 12 | 2 | 14 | | 2006 | 12 | 2 | 14 | | 2007 | 11 | 2 | 13 | | 2008 | 13 | 3 | 16 | | 2009 | 10 | 7 | 17 | | 2010 | 8 | 3 | 11 | | 2011 | 16 | 3 | 19 | | 2012 | 13 | 7 | 20 | | 2013 | 27 | 5 | 32 | | 2014 | 24 | 5 | 29 | | 2015 | 19 | 4 | 23 | | 2016 | 8 | 3 | 11 | | 2017 | 7 | 0 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Heart Failure" by people in Profiles.
-
Sano S, Oshima K, Wang Y, MacLauchlan S, Katanasaka Y, Sano M, Zuriaga MA, Yoshiyama M, Goukassian D, Cooper MA, Fuster JJ, Walsh K. Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1ß/NLRP3 Inflammasome. J Am Coll Cardiol. 2018 02 27; 71(8):875-886.
-
Kiernan MS, Grandin EW, Brinkley M, Kapur NK, Pham DT, Ruthazer R, Rame JE, Atluri P, Birati EY, Oliveira GH, Pagani FD, Kirklin JK, Naftel D, Kormos RL, Teuteberg JJ, DeNofrio D. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail. 2017 Oct; 10(10).
-
Gurwitz JH, Magid DJ, Smith DH, Tabada GH, Sung SH, Allen LA, McManus DD, Goldberg RJ, Tisminetzky M, Go AS. Treatment Effectiveness in Heart Failure with Comorbidity: Lung Disease and Kidney Disease. J Am Geriatr Soc. 2017 Dec; 65(12):2610-2618.
-
Kapur NK, Esposito ML, Bader Y, Morine KJ, Kiernan MS, Pham DT, Burkhoff D. Mechanical Circulatory Support Devices for Acute Right Ventricular Failure. Circulation. 2017 Jul 18; 136(3):314-326.
-
Qureshi WT, Nasir UB. Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure. Heart Fail Rev. 2017 07; 22(4):491-499.
-
Pandolfi MM, Wang Y, Spenard A, Johnson F, Bonner A, Ho SY, Elwell T, Bakullari A, Galusha D, Leifheit-Limson E, Lichtman JH, Krumholz HM. Associations between nursing home performance and hospital 30-day readmissions for acute myocardial infarction, heart failure and pneumonia at the healthcare community level in the United States. Int J Older People Nurs. 2017 Dec; 12(4).
-
Son AY, Stein LH, DeAnda A, Katz SD, Smith DE, Reyentovich A, Balsam LB. Impact of chlorhexidine gluconate intolerance on driveline infection during chronic HeartMate II left ventricular assist device support. Int J Artif Organs. 2017 01 13; 39(11):570-574.
-
Koeckert M, Vining P, Reyentovich A, Katz SD, DeAnda A, Philipson S, Balsam LB. Caregiver status and outcomes after durable left ventricular assist device implantation. Heart Lung. 2017 Mar - Apr; 46(2):74-78.
-
Wiklund I, Anatchkova M, Oko-Osi H, von Maltzahn R, Chau D, Malik FI, Patrick DL, Spertus J, Teerlink JR. Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program. Health Qual Life Outcomes. 2016 Sep 15; 14(1):131.
-
Morine KJ, Paruchuri V, Qiao X, Aronovitz M, Huggins GS, DeNofrio D, Kiernan MS, Karas RH, Kapur NK. Endoglin selectively modulates transient receptor potential channel expression in left and right heart failure. Cardiovasc Pathol. 2016 Nov - Dec; 25(6):478-482.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|